Glaucoma-related ocular surface disease (G-OSD) is a significant, yet often
underdiagnosed, ocular co-morbidity affecting 40% to 59% of glaucoma patients worldwide …

Purpose To assess the literature on the effects of topical intraocular pressure (IOP)-lowering
medications on the ocular surface. Ocular surface assessment in these patients is seldom a …

For many years, blepharitis and dry eye disease have been thought to be two distinct
diseases, and evaporative dry eye distinct from aqueous insufficiency. In this treatise, we …

Purpose To examine the relationship between ocular surface disease (OSD) and topical
antiglaucoma therapy. Methods A total of 211 eyes of 211 patients with open-angle …

Purpose To assess tear film parameters, ocular surface characteristics, and dry eye
symptomology in patients receiving topical anti-glaucoma medications. Methods Thirty-three …

Although the pathophysiology of meibomian gland dysfunction (MGD) remains incompletely
understood, many treatment options have recently become available. According to an …

Meibomian gland dysfunction is one of the main causes of dry eye disease and has limited
therapeutic options. In this study, we investigated the biological function of the beta 2 …

Purpose: The purpose of this study was to evaluate the effect of treating ocular surface
disease (OSD) in patients with medically uncontrolled primary open-angle glaucoma …

Purpose: Investigators have discovered that topical antiglaucoma drugs may induce
meibomian gland dysfunction. This response may contribute to the dry eye disease …

The Tear Film (TF) is a trilaminar and dynamic fluid covering the entire Ocular Surface (OS),
consisting of a mucus, aqueous, and lipid layer deeply interacting between them. Because …